The effects of p-hydroxycinnamaldehyde from Alpinia galanga extracts on human chondrocytes |
| |
Authors: | Thanyaluck Phitak Peraphan Pothacharoen Bhusana Premanode |
| |
Institution: | a Thailand Excellence Center for Tissue Engineering, Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand b Faculty of Science, Lampang Rajabhat University, Lampang, Thailand c Institute of Biomedical Engineering, Imperial College, London SW7 2AZ, UK |
| |
Abstract: | Osteoarthritis (OA) is the most common form of arthritis and affects millions of people worldwide. Patients have traditionally been treated with non-steroidal anti-inflammatory drugs (NSAIDs), but these are associated with significant side effects. Purification of the acetone extract of Alpinia galanga afforded p-hydroxycinnamaldehyde, as identified by nuclear magnetic resonance and mass spectrometry analyses. By exploiting the cartilage explant culture, p-hydroxycinnamaldehyde suppressed loss of uronic acid, resulting in release of hyaluronan (HA), sulfated glycosaminoglycans (s-GAGs) and matrix metalloproteinases (MMPs). p-Hydroxycinnamaldehyde and interleukin-1β (IL-1β), when incubated in primary human chondrocytes, also reduced release of HA, s-GAG and MMP-2. The results demonstrated: (a) that expression levels of the catabolic genes MMP-3 and MMP-13 were suppressed and (b) mRNA expression levels of anabolic genes of collagen II, SOX9 and aggrecan were increased. This study shows that p-hydroxycinnaldehyde from A. galanga Linn. is a potential therapeutic agent for treatment of OA. |
| |
Keywords: | Alpinia galanga Zingiberaceae Kha (Thailand) Osteoarthritis Phenolic compound p-Hydroxycinnamaldehyde |
本文献已被 ScienceDirect 等数据库收录! |
|